Navigation Links
Patients Can Now Visit Their Dentist for Treatment and Monitoring of Sleep Apnea
Date:11/28/2011

he Moses™, the EMA® First Step and EMA® Custom oral appliances as well as marketing materials and other useful tools for the dentist to incorporate this therapy solution into their practice.  This selected range of oral appliances offer options suited to all types of patients. These appliances are all FDA cleared for the treatment of snoring and mild to moderate sleep apnea, or for patients that cannot tolerate CPAP (Continuous Positive Air Pressure).

The final component of the Sleep Complete package is the WatchPAT™ testing device provided through Itamar Medical.  WatchPAT is a user-friendly, non-invasive, portable sleep testing device that gathers data related to the patient's sleep tendencies that can be interpreted by a sleep physician and used by the dentist to titrate the oral appliance being used for the treatment of obstructive sleep apnea.  Dentists utilize the WatchPAT portable sleep monitoring device in collaboration with the patient's physician. 

"Sleep apnea is a serious health problem, and dental sleep medicine presents a very promising practice extension opportunity for dentists," said Tim Sullivan, President of Henry Schein Dental.  "Our Sleep Complete program provides all of the key tools and guidance necessary to help dentists easily navigate the intricacies of treatment, reimbursement and monitoring, and makes it simple for our dentist customers to successfully incorporate dental sleep medicine into their practices."

Sleep apnea, which occurs when the tongue and soft tissues fall back into the throat and block the airway during sleep, is a very serious health condition.  According to the American Academy of Sleep Medicine, approximately one-half of people who snore loudly have obstructive sleep apnea, which can contribute to an increased risk for high blood pressure, heart attack, stroke, diabetes, depression, memory and concentration problems, obesity, excessive daytime sl
'/>"/>

SOURCE Henry Schein, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. Many Heart Attack Patients Dont Get Best Emergency Treatment
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
11. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Fla. , March 3, 2015 ... pleased to announce the hiring of Brian ... to lead business development efforts and build relationships ... of experience in software development, sales, and sales ... enterprise software applications. iTraycer is a comprehensive inventory ...
(Date:3/3/2015)... -- Dr. Cummins is known for being one of ... In addition to performing cosmetic and hand surgery at ... Cummins now offers advanced laser tattoo removal treatments at ... performs all treatments himself using the industry-leading Astanza Duality ... order to help people take back control over the ...
(Date:3/3/2015)... --   Clinical trials at ... Publications in peer reviewed journals Gastrointestinal Endoscopy ... diagnostic value of confocal laser endomicroscopy in treatment of ... across Asia   ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today ...
Breaking Medicine Technology:Medical Tracking Solutions, Inc. Hires New SVP, Sales 2Surgeon Owned And Operated Louisville Tattoo Removal Offers Astanza Duality Laser Treatments 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 3Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 4
... Disease Research Interchange, a Philadelphia-based national human tissue center ... awarded a $3.59 million subcontract from the National Institutes ... (Genotype-Tissue Expression). The funds for the 30-month project are ... NCI (the National Cancer Institute), NIMH (the National Institute ...
... FOUNTAIN HILLS, Ariz., Oct. 13 Sunridge International (OTC ... received an order for additional inventory from New Amsterdam ...  New Amsterdam personnel are currently on a two-week marketing ...  New Amsterdam,s personnel is accompanied by Leo D. Bores ...
Cached Medicine Technology:NDRI Has Been Awarded $3.59 Million From the National Institutes of Health, 'The Directors Common Fund' to Provide Human Tissue for 'GTEx,' the New Genotype-Tissue Expression Project 2NDRI Has Been Awarded $3.59 Million From the National Institutes of Health, 'The Directors Common Fund' to Provide Human Tissue for 'GTEx,' the New Genotype-Tissue Expression Project 3NDRI Has Been Awarded $3.59 Million From the National Institutes of Health, 'The Directors Common Fund' to Provide Human Tissue for 'GTEx,' the New Genotype-Tissue Expression Project 4
(Date:3/3/2015)... The human augmentation market is mainly driven ... wearable augmentation sector is predicted to outpace the in-built ... years. , The eye-wear sector dominates the North ... of new products launches in the region. Furthermore, strong ... as well as the rising demand for advantageous products ...
(Date:3/3/2015)... While it is clear that the prospect of reduced ... are signing up to UBI policies, more mature audiences ... Due to current regulations, the application of UBI in ... full capability is starting to be realised in the ... services are at the top of the value-added services ...
(Date:3/3/2015)... 03, 2015 DePuy Pinnacle hip ... version of the artificial hip system caused recipients ... move forward in the federal multidistrict litigation underway ... According to the most recent Master Case List ... 7,350 Pinnacle hip replacement lawsuits are now pending ...
(Date:3/3/2015)... BC (PRWEB) March 03, 2015 The ... doubled since 1984 to about 15%. This increases to ... old. (Bushnik T, Cook JL, Yuzpe AA, et al. ... 2012; 27: 738-46). Dr. Jason Hitkari, a reproductive endocrinologist ... a doctor of TCM and clinical director and founder ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 ... is estimated to grow from $1,224.6 million ... 6.71% between 2014 and 2019. , Browse ... delivery network market for an analysis of ... of various tables and figures., http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html ...
Breaking Medicine News(10 mins):Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3
... HOPKINTON, Mass., Sept. 14 EMC Corporation (NYSE: ... infrastructure solutions, today announced that eClinicalWorks, a market leader ... provider customers, has consolidated and enhanced security of its ... As a result, eClinicalWorks has successfully managed rapid business ...
... , , ITASCA, Ill., Sept. 14 ... the JEWEL-OSCO grocery checkout. , , Starting today ... pharmacy will receive a special invitation to save a total of 20 ... avoid serious complications that can result from certain other illnesses or health conditions. ...
... , , , ... revealing that ten percent of Americans face dangerous drinking water, the Water ... their homes. , , On Sunday, the newspaper reported ... on "toxic waters." Among its findings: , , ...
... WILMINGTON, Del., Sept. 14 The airline and pharmaceutical industries ... can be dangerous if the risks are not properly calculated and ... experience of people who make and fly airplanes? , , ... a recent webinar on the topic - Captain Ben Berman, senior ...
... , , , ... today announced it has received the Frost & Sullivan 2009 ... of the Year Award . The award highlights PolyOne,s continuous innovations ... Walter Ripple, general manager, PolyOne,s GLS Thermoplastic Elastomers (TPEs), ...
... CHERRY HILL, N.J., Sept. 14 Nuvilex, Inc. (OTC Bulletin ... sponsored research studies indicate that Oraphyte(TM) can control nematode infestation ... coming months Nuvilex intends to initiate trials on golf course ... most optimal for turfgrass growth. These commercial studies will determine ...
Cached Medicine News:Health News:eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 2Health News:eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 3Health News:JEWEL-OSCO PHARMACY Offers Grocery Savings to Flu Shot Customers 2Health News:Home Filtering Systems Provide Best Drinking Water Protection 2Health News:Webinar Explores Drug Safety Lessons Pharma Can Learn from Airline Industry 2Health News:PolyOne Presented with Frost & Sullivan Medical Product Award 2Health News:Nuvilex, Inc. Announces Positive Oraphyte(TM) Microplot Results 2Health News:Nuvilex, Inc. Announces Positive Oraphyte(TM) Microplot Results 3Health News:Nuvilex, Inc. Announces Positive Oraphyte(TM) Microplot Results 4
ELISA kit for Varicella-zoster IgM....
ELISA kit for Varicella-zoster IgG....
The DSL-05-10-VZM Varicella Zoster IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Varicella Zoster Virus in human serum. This as...
... Scientific, Inc. Mumps IgG ELISA test system ... Mumps IgG antibody in human serum. When ... of this test, together with other clinical ... immune status, and/or aid in the diagnosis ...
Medicine Products: